The Seeker Health digital patient enrollment platform is intended to help trial teams find patients from populations that are typically hard to connect with.
The two companies, along with Datavant, will combine real-world data and decentralized platforms to yield better patient information management and insights.
Leaders from ArisGlobal and Eversana explain the benefits of carefully selecting a research partner with a robust set of capabilities to see a project through.
The two companies have joined forces to collaborate on the commercial launch of Gimoti, a nasal spray for patients suffering from diabetic gastroparesis.
The technology combines predictive analytics and commercial services to help pharma firms and partners maximize drug discovery and development efforts.
Eversana boosts its logistics offering by opening its fourth storage and distribution center in the US, bringing its total footprint to one million-square-feet.
Eversana adopts Cryoport’s full suite of logistics services, in an alliance expected to ‘drive synergistic growth’ for both companies and answer regenerative medicine demands.
